Trial Identifier: | D7460C00004 |
Sponsor: | AstraZeneca |
Collaborator: |
Parexel
|
NCTID:: | NCT06406400 |
Start Date: | May 2024 |
Primary Completion Date: | May 2026 |
Study Completion Date: | May 2026 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
US, MD | Baltimore, MD, US, 21225 |